The landscape of HIV prevention has undergone a profound transformation with significant advancements in medical interventions and a deeper understanding of how the virus spreads. These developments ...

MEXICO CITY — It’s been called the closest the world has ever come to a vaccine against the AIDS virus. The twice-yearly shot was 100% effective in preventing HIV infections in a study of women, and ...

Jared Baeten, MD, PhD, discusses the significance of the PURPOSE 1 trial results, which found that lenacapavir for pre-exposure prophylaxis resulted in no new infections of HIV. How significant is it ...

A groundbreaking medical advancement could reshape the future of HIV prevention. In a landmark clinical trial, a twice-yearly injection of lenacapavir demonstrated an astonishing 96% effectiveness in ...

On June 5, South Africa is about to begin one of its most important HIV prevention drives in decades. The country will start to roll out an HIV prevention injection that has to be taken only twice a ...

From March 2026, people at high risk of contracting HIV will be able to visit their local clinic every six months for an HIV-prevention jab. The treatment combines a Lenacapavir injection with a short ...

The number of new HIV infections has fallen over the years – it declined by 39% from 2010 to 2023. But HIV’s devastating impact on global health persists. In 2023, 1.3 million people acquired HIV – ...

"Pre-exposure prophylaxis (PrEP) is the most important concept in the [HIV] prevention field today," Robert Grant told the Infectious Disease Society of America at their annual meeting in San Diego.

In the quest to overcome quality-of-life altering side effects linked to combination antiretroviral therapy (cART) in people with HIV, a team of Johns Hopkins researchers has developed a new way to ...

Accurate estimation of HIV incidence—the rate of new infections in a population—is essential for guiding prevention strategies, allocating resources and evaluating the impact of interventions. Methods ...